These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17385845)

  • 1. The influence of fluoroquinolone drugs on the bacterial growth of S. epidermidis utilizing the unique potential of vibrational spectroscopy.
    Neugebauer U; Schmid U; Baumann K; Ziebuhr W; Kozitskaya S; Holzgrabe U; Schmitt M; Popp J
    J Phys Chem A; 2007 Apr; 111(15):2898-906. PubMed ID: 17385845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bacterial growth and the influence of antibiotics by means of UV resonance Raman spectroscopy.
    Neugebauer U; Schmid U; Baumann K; Holzgrabe U; Ziebuhr W; Kozitskaya S; Kiefer W; Schmitt M; Popp J
    Biopolymers; 2006 Jul; 82(4):306-11. PubMed ID: 16421857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a detailed understanding of bacterial metabolism--spectroscopic characterization of Staphylococcus epidermidis.
    Neugebauer U; Schmid U; Baumann K; Ziebuhr W; Kozitskaya S; Deckert V; Schmitt M; Popp J
    Chemphyschem; 2007 Jan; 8(1):124-37. PubMed ID: 17146809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vibrational spectroscopic characterization of fluoroquinolones.
    Neugebauer U; Szeghalmi A; Schmitt M; Kiefer W; Popp J; Holzgrabe U
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 May; 61(7):1505-17. PubMed ID: 15820884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.
    Almahmoud I; Kay E; Schneider D; Maurin M
    J Antimicrob Chemother; 2009 Aug; 64(2):284-93. PubMed ID: 19474069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
    Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
    Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
    Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
    Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
    Jhanji V; Sharma N; Satpathy G; Titiyal J
    J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis.
    Noreddin AM; Reese AA; Ostroski M; Hoban DJ; Zhanel GG
    Clin Ther; 2007 Dec; 29(12):2685-9. PubMed ID: 18201584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the mode of action of antibiotics using Raman spectroscopy: investigating subinhibitory effects of amikacin on Pseudomonas aeruginosa.
    López-Díez EC; Winder CL; Ashton L; Currie F; Goodacre R
    Anal Chem; 2005 May; 77(9):2901-6. PubMed ID: 15859609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.
    Allen GP; Hankins CD
    J Antimicrob Chemother; 2009 Aug; 64(2):359-63. PubMed ID: 19460783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photophysical and phototoxic properties of the antibacterial fluoroquinolones levofloxacin and moxifloxacin.
    Viola G; Facciolo L; Canton M; Vedaldi D; Dall'Acqua F; Aloisi GG; Amelia M; Barbafina A; Elisei F; Latterini L
    Chem Biodivers; 2004 May; 1(5):782-801. PubMed ID: 17191880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman spectroscopic discrimination of cell response to chemical and physical inactivation.
    Escoriza MF; VanBriesen JM; Stewart S; Maier J
    Appl Spectrosc; 2007 Aug; 61(8):812-23. PubMed ID: 17716399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
    Schafer J; Hovde LB; Simonson D; Rotschafer JC
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies.
    Vickers AA; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2007 Aug; 60(2):269-73. PubMed ID: 17556355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
    Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying bacterial metabolic states using Raman spectroscopy.
    Escoriza MF; Vanbriesen JM; Stewart S; Maier J
    Appl Spectrosc; 2006 Sep; 60(9):971-6. PubMed ID: 17002820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial type II topoisomerases as targets for antibacterial drugs].
    Pietrusiński M; Staczek P
    Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.